CLINICAL_TRIALS
trial_result
· 2007-10-12
Clinical Trial Update: FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent [Phase 1, Phase 2]
Summary
Completion of a first-in-man Phase 1/2 Netherlands study evaluating a sirolimus-coated BX Velocity coronary stent.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 1, Phase 2 | Status: COMPLETED